OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc.

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

Researchers have demonstrated a new way to precisely place quantum light sources on chips ...

Explore digital PCR’s potential, how the technology has transformed life science research, the challenges it faces and what ...

Scientists are exploring DNA-based robots, tiny molecular machines that could one day navigate the body, deliver targeted therapies, and even build nanoscale technologies.

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production.

When a virus infects a bacterial cell, the viral genome is the first component to be fully injected into the cell, making it an ideal immune target. A bacterial enzyme anchored to the membrane ...

The field of RNA-targeted therapeutics is rapidly evolving, offering groundbreaking opportunities for the treatment of a wide array of diseases ...